Moderna ٧ مايو ٢٠٢٦ Moderna’s mRNA flu vaccine more effective than current SOC - Clinical Trials Arena
Moderna ٧ مايو ٢٠٢٦ Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 - Brussels Signal
Moderna ٧ مايو ٢٠٢٦ Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults - CIDRAP
Moderna ٥ مايو ٢٠٢٦ Boston biotech firms back new effort to preserve U.S. edge in life sciences - The Business Journals
Moderna ٤ مايو ٢٠٢٦ Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues - Fierce Biotech
Moderna ٤ مايو ٢٠٢٦ Biopharma bites: Tolerability sinks Vertex-Moderna's CF candidate, Takeda's immune win, and more from Amgen, Latus - FirstWord Pharma
Moderna ١ مايو ٢٠٢٦ Moderna sees revenue bump from international COVID vaccine sales - BioPharma Dive
Moderna ٣٠ أبريل ٢٠٢٦ Moderna loses key mRNA patent in European vaccine fight - Life Sciences Intellectual Property Review
Moderna ٢٨ أبريل ٢٠٢٦ Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations - HIT Consultant
Moderna ٢٨ أبريل ٢٠٢٦ CureVac targets Moderna with 10-patent suit over Spikevax - Life Sciences Intellectual Property Review
Moderna ٢٢ أبريل ٢٠٢٦ Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial - BioPharma Dive
Moderna ٢٢ أبريل ٢٠٢٦ Moderna launches mRNA bird flu vaccine trial after HHS cancels funding - The Washington Post
Moderna ٢١ أبريل ٢٠٢٦ Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
Moderna ٢٠ أبريل ٢٠٢٦ Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNEXSPIKE - Fierce Pharma